Approval followed priority review and was based on response rates and duration of response demonstrated in the phase 1b ...

The FDA approved Hernexeos for adults with unresectable or metastatic non-squamous non-small cell lung cancer.

GlaxoSmithKline plc (UK) (($GB:GSK)) announced an update on their ongoing clinical study. GlaxoSmithKline (GSK) is ...

Rheumatoid arthritis (RA) commonly causes joint damage and fatigue, but it may sometimes cause symptoms that affect your skin ...

Baron Capital highlights biotech and robotic surgery as key growth drivers in Q2. See which stocks surged, which stumbled, ...

Added to Russell 3000® Index: In June 2025, Tectonic was added to the Russell 3000® Index as part of FTSE Russell’s annual reconstitution. Inclusion in the index broadens the company’s exposure to ...

Patients with inflammatory bowel disease (IBD) have a 48% greater relative risk of developing interstitial lung disease (ILD) ...

A new study meticulously sampled different lung regions in people with cystic fibrosis to understand why infections persist ...

A new AI tool helps predict survival in fibrotic lung disease, outperforming traditional clinical and imaging methods in a study of over 1,200 patients.

Investing in clinical-stage biotechnology always carries significant risks, and aTyr is no exception. The company reported a ...